Mode
Text Size
Log in / Sign up
N/A Completed N=73 Randomized Double-blind Treatment

Total Knee Replacement With Tourniquet or Aquamantys

Knee Replacement
Source: ClinicalTrials.gov NCT04016285 ↗
Enrolled (actual)
73
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcomePrimary: Isometric Quadriceps Strength — 11.58; 9.60 Nm/kg

Summary

The purpose of this study is to compare quadriceps muscle strength, pain, opioid consumption and patient function during the first three months after short-stay total knee replacement between patients treated with short-duration tourniquet knee replacement with the Aquamantys® bipolar sealer versus those treated with the standard of care (tourniquet used throughout the case and no Aquamantys®). By doing this study, investigators hope to learn if short duration tourniquet knee replacement with the Aquamantys® bipolar sealer is more effective than standard of care (tourniquet used throughout the case and no Aquamantys®). The purpose of this study is to compare quadriceps muscle strength, pain, opioid consumption and patient function during the first three months after short-stay total knee replacement between patients treated with short-duration tourniquet knee replacement with the Aquamantys® bipolar sealer versus those treated with the standard of care (tourniquet used throughout the case and no Aquamantys®).

Outcome Measures

OutcomeResultp-value
PRIMARY
Isometric Quadriceps Strength
SECONDARY
Pain (VAS)
SECONDARY
Knee Osteoarthritis (KOOS,JR)
13; 10; 16; 17
SECONDARY
Emotional Health (VR-12 MCS)
SECONDARY
Knee Function Questionnaire
SECONDARY
Sit to Stand Test
SECONDARY
Opioid Use
SECONDARY
Isometric Quadriceps Strength

Eligibility Criteria

Inclusion Criteria

  • primary total knee arthroplasty

Exclusion Criteria

  • repeat knee replacement (revision arthroplasty)
  • bilateral knee replacements on the same day
  • partial knee replacements
  • health or social limitations that do not allow for the participant to be discharged to home on the same day or day after surgery.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04016285). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search